DEVELOPMENT AND EVALUATION OF THE COMMENT AID SYSTEM FOR THERAPEUTIC DRUG-MONITORING .1. APPLICATION TO VALPROATE

被引:0
|
作者
OHTANI, H [1 ]
KOHDA, Y [1 ]
YAMAMOTO, K [1 ]
IGA, T [1 ]
机构
[1] UNIV TOKYO HOSP, FAC MED, DEPT PHARM, 3-1 HONGO 7 CHOME, BUNKYO KU, TOKYO 113, JAPAN
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1991年 / 111卷 / 12期
关键词
TDM; CONSULTATION; EXPERT SYSTEM; BAYESIAN; VALPROATE; DOSAGE REGIMEN; FUZZY THEORY; ANTICONVULSANT;
D O I
10.1248/yakushi1947.111.12_783
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A comment aid system for therapeutic drug monitoring (TDM), which produces the primary comment on the dosage regimen of valproate, was developed. This system produces consulting comments with a fuzzy theory, by using the dosage regimen of valproate, pharmacokinetic parameters estimated by the Bayesian method, and therapeutic effect and toxicity of anticonvulsants evaluated by the physician. For nearly 90% in 42 cases, comments of the system were agreeable comparing with the notes of TDM technologists. There are a few disagreements between this system and experts, mainly because the system does not use enough information about combination therapy with other anticonvulsants. Developed comment aid system shows some clinical and educational utility, and suggests significance and possibility of more useful and allround TDM expert system. Then this system might be available as a prototype of the TDM expert system.
引用
收藏
页码:783 / 789
页数:7
相关论文
共 50 条
  • [21] EVALUATION OF THERAPEUTIC DRUG-MONITORING OF METHOTREXATE IN SALIVA OF CHILDREN WITH RHEUMATIC DISEASES
    PRESS, J
    BERKOVITCH, M
    LAXER, R
    GIESBRECHT, E
    SILVERMAN, E
    KLEIN, J
    KOREN, G
    THERAPEUTIC DRUG MONITORING, 1995, 17 (03) : 247 - 250
  • [22] THERAPEUTIC DRUG-MONITORING - CONCEPTS, ANALYTICAL METHODOLOGY AND CLINICAL-APPLICATION
    MIRA, SA
    ALFARES, AM
    TAYEB, OS
    SOLIMAN, SA
    ISLAM, SI
    SAUDI MEDICAL JOURNAL, 1985, 6 (06) : 581 - 591
  • [23] APPLICATION OF RATE NEPHELOMETRIC INHIBITION IMMUNOASSAY FOR EMERGENCY AND THERAPEUTIC DRUG-MONITORING
    QUATTRONE, AJ
    JONES, JT
    JOSEPH, R
    VETERINARY AND HUMAN TOXICOLOGY, 1983, 25 (04) : 285 - 286
  • [24] NEONATAL DRUG-MONITORING .1. PHYSICIANS POINT OF VIEW
    MACDONALD, M
    CLINICAL CHEMISTRY, 1984, 30 (06) : 1084 - 1084
  • [25] EVALUATION OF THERAPEUTIC DRUG-MONITORING SERVICES IN KYUSHU-UNIVERSITY-HOSPITAL
    IEIRI, I
    HIGUCHI, S
    OKABE, M
    SYUTO, H
    SUEYASU, M
    YOSHIKAWA, M
    YUKAWA, E
    AOYAMA, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S111 - S111
  • [26] THERAPEUTIC DRUG-MONITORING IN PATIENTS WITH CHRONIC-RENAL-FAILURE - EVALUATION OF THE ABBOTT TDX DRUG ASSAY SYSTEM
    SEDMAN, AJ
    MOLITORIS, BA
    NAKATA, LM
    GAL, J
    AMERICAN JOURNAL OF NEPHROLOGY, 1986, 6 (02) : 132 - 134
  • [27] EVALUATION OF THE IL TDM CAL-1 MULTICOMPONENT CALIBRATOR SET FOR THERAPEUTIC DRUG-MONITORING
    GARCIA, L
    CHAN, TH
    CHASE, A
    KIM, J
    SOYBEL, J
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1104 - 1104
  • [28] EVALUATION OF THE COBAS-BIO CENTRIFUGAL ANALYZER FOR THERAPEUTIC DRUG-MONITORING OPTIMIZATION OF EMIT REAGENT SYSTEM
    OU, CN
    FRAWLEY, VL
    BUFFONE, GJ
    CLINICAL CHEMISTRY, 1981, 27 (06) : 1090 - 1090
  • [29] THE VALUE OF THERAPEUTIC DRUG-MONITORING TO THE PRACTICING PHYSICIAN - AN HYPOTHESIS NEEDING SENSIBLE APPLICATION
    WATSON, ID
    THOMSON, AH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) : 619 - 620
  • [30] COMMUNITY-BASED THERAPEUTIC DRUG-MONITORING - USEFUL DEVELOPMENT OR UNNECESSARY DISTRACTION
    CAMPBELL, M
    CLINICAL PHARMACOKINETICS, 1995, 28 (04) : 271 - 274